SINOPHARM (01099): China National Accord Medicines Corporation (000028.SZ) is expected to achieve a net profit attributable to the parent company of 1.136 billion yuan in 2025, representing a year-on-year increase of 76.8%.

07:14 18/03/2026

China National Pharmaceutical Group Corporation (01099) released the 2025 interim report of China National Pharmaceutical Group Co., Ltd. (000028.SZ), with a total operating income of 73.416 billion yuan, a decrease of 1.29% year-on-year; net profit attributable to shareholders of the listed company was 1.136 billion yuan, an increase of 76.8% year-on-year; basic earnings per share was 2.04 yuan.

SINOPHARM (01099) released the 2025 interim performance report of China National Accord Medicines Corporation (000028.SZ), with total operating income of 73.416 billion yuan, a decrease of 1.29% year-on-year; net profit attributable to shareholders of the listed company was 1.136 billion yuan, an increase of 76.8% year-on-year; basic earnings per share were 2.04 yuan.

CITIC SEC: The wind power industry welcomes a super MEGA opportunity with high prosperity + and structural .

RUSAL (00486) reported an annual adjusted net loss of 787 million US dollars, a turnaround from profit to loss year-on-year.

Broker morning meeting essence | NVIDIA GTC conference LPU integration speed exceeds expectations

CITIC SEC: The wind power industry welcomes a super MEGA opportunity with high prosperity + and structural .

RUSAL (00486) reported an annual adjusted net loss of 787 million US dollars, a turnaround from profit to loss year-on-year.

Broker morning meeting essence | NVIDIA GTC conference LPU integration speed exceeds expectations